C. Dayen

1.1k total citations
44 papers, 551 citations indexed

About

C. Dayen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, C. Dayen has authored 44 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in C. Dayen's work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Research Studies (12 papers). C. Dayen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Research Studies (12 papers). C. Dayen collaborates with scholars based in France, United Kingdom and Hungary. C. Dayen's co-authors include Y. Douadi, D. Debieuvre, Olivier Molinier, M Grivaux, Bernard Asselain, H. Bentayeb, Chrystèle Locher, Francis Martin, D. Coëtmeur and V. Jounieaux and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

C. Dayen

39 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Dayen France 13 319 254 87 82 61 44 551
Piotr Krysiak United Kingdom 11 183 0.6× 157 0.6× 133 1.5× 43 0.5× 98 1.6× 25 445
Hayato Koba Japan 10 180 0.6× 85 0.3× 61 0.7× 30 0.4× 30 0.5× 46 361
Toshihiro Yamashita Japan 15 349 1.1× 130 0.5× 54 0.6× 22 0.3× 102 1.7× 40 555
Chun‐Liang Chou Taiwan 12 120 0.4× 132 0.5× 79 0.9× 23 0.3× 35 0.6× 26 607
Tanu Garg United States 8 52 0.2× 163 0.6× 83 1.0× 112 1.4× 52 0.9× 25 363
Ulrich Wulbrand Germany 13 326 1.0× 94 0.4× 91 1.0× 63 0.8× 46 0.8× 18 593
Francesca Scuderi Italy 9 64 0.2× 214 0.8× 68 0.8× 74 0.9× 21 0.3× 19 403
Branko Dmitrović Croatia 11 76 0.2× 142 0.6× 59 0.7× 44 0.5× 118 1.9× 56 497
Frank Aboubakar Nana Belgium 14 171 0.5× 184 0.7× 21 0.2× 121 1.5× 22 0.4× 29 510

Countries citing papers authored by C. Dayen

Since Specialization
Citations

This map shows the geographic impact of C. Dayen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dayen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dayen more than expected).

Fields of papers citing papers by C. Dayen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dayen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dayen. The network helps show where C. Dayen may publish in the future.

Co-authorship network of co-authors of C. Dayen

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dayen. A scholar is included among the top collaborators of C. Dayen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dayen. C. Dayen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molinier, O., J. Pinsolle, Sebastian Schneider, et al.. (2024). COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study. Respiratory Medicine and Research. 86. 101093–101093. 1 indexed citations
2.
Masliah‐Planchon, Julien, Manuel Delgado‐Fernández, Innocenti Dadamessi, et al.. (2024). Major response of a peritoneal mesothelioma to nivolumab and ipilimumab: a case report, molecular analysis and review of literature. Frontiers in Oncology. 14. 1410322–1410322. 2 indexed citations
3.
4.
Douadi, Y., et al.. (2021). Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature. BMC Infectious Diseases. 21(1). 499–499. 8 indexed citations
5.
Bentayeb, H., et al.. (2021). A case of Francisella tularensis meningitis in a 64-year-old man treated with quinolones. Infectious Diseases Now. 52(2). 107–109. 4 indexed citations
6.
7.
Debieuvre, D., L. Moreau, Mathieu Coudert, et al.. (2019). Erlotinib en 2e ou 3e ligne pour les cancers bronchiques non à petites cellules sans mutation de l’EGFR : données en vie réelle. Revue des Maladies Respiratoires. 36(6). 649–663. 1 indexed citations
8.
Debieuvre, D., Chrystèle Locher, Bernard Asselain, et al.. (2019). Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies. Bulletin du Cancer. 106(4). 283–292. 15 indexed citations
9.
Antoine, Martine, Denis Moro‐Sibilot, C. Dayen, et al.. (2018). Inhibiteurs du check-point immunitaire en néo-adjuvant dans les cancers bronchiques non à petites cellules localisés : essai IoNESCO. Revue des Maladies Respiratoires. 35(9). 983–988. 11 indexed citations
10.
Basille, Damien, C. Dayen, Y. Douadi, et al.. (2018). Échobronchoscopie avec ponction transbronchique à l’aiguille : évaluation des pratiques. Revue des Maladies Respiratoires. 35(3). 305–312.
11.
Grivaux, M, François Goupil, Bernard Asselain, et al.. (2017). Stratégies thérapeutiques les 2 premières années après un diagnostic de cancer du poumon. ESCAP-2011-CPHG, étude en situation réelle réalisée dans les hôpitaux généraux français. Revue des Maladies Respiratoires. 34(9). 991–999. 7 indexed citations
12.
Dewolf, Maxime, et al.. (2017). Efficacité de l’erlotinib en réanimation chez les patients présentant un cancer bronchique non à petites cellules avec une mutation de l’EGFR. Revue de Pneumologie Clinique. 73(3). 135–139. 3 indexed citations
13.
14.
Bentayeb, H., et al.. (2014). Hyponatrémie sévère sous chimiothérapie du carcinome à petites cellules. Revue des Maladies Respiratoires. 32(1). 52–57. 1 indexed citations
15.
16.
Locher, Chrystèle, D. Debieuvre, D. Coëtmeur, et al.. (2013). Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies. Lung Cancer. 81(1). 32–38. 74 indexed citations
17.
Lanoix, Jean‐Philippe, François Xavier Lescure, H. Bentayeb, et al.. (2011). Bacterial infection profiles in lung cancer patients with febrile neutropenia. BMC Infectious Diseases. 11(1). 183–183. 44 indexed citations
18.
Berna, Pascal, Patrick Bagan, Florence De Dominicis, et al.. (2011). Aortic Endostent Followed by Extended Pneumonectomy for T4 Lung Cancer. The Annals of Thoracic Surgery. 91(2). 591–593. 21 indexed citations
19.
20.
Douadi, Y., H. Bentayeb, Seth Malinowski, et al.. (2009). Anesthésie en échoendoscopie bronchique : expérience du masque laryngé. Revue des Maladies Respiratoires. 27(1). 37–41. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr Krysiak Breakdown of academic impact, for papers by Hayato Koba Breakdown of academic impact, for papers by Toshihiro Yamashita Breakdown of academic impact, for papers by Chun‐Liang Chou Breakdown of academic impact, for papers by Tanu Garg Breakdown of academic impact, for papers by Ulrich Wulbrand Breakdown of academic impact, for papers by Francesca Scuderi Breakdown of academic impact, for papers by Branko Dmitrović Breakdown of academic impact, for papers by Frank Aboubakar Nana
Rankless by CCL
2026